改善 COPD 患者药物依从性的障碍和策略:系统评价。
Barriers and Strategies for Improving Medication Adherence Among People Living With COPD: A Systematic Review.
机构信息
School of Pharmacy and Pharmacology, Quality Use of Medicines Network, Menzies Health Institute Queensland, Griffith University, Gold Coast, Australia.
School of Public Health and Community Medicine, The University of New South Wales, Sydney, Australia.
出版信息
Respir Care. 2020 Nov;65(11):1738-1750. doi: 10.4187/respcare.07355. Epub 2020 Jun 23.
BACKGROUND
While medication is an integral component of the effective management of COPD, contemporary studies report that more than half of all people who are prescribed medication for the management of their COPD do not adhere to therapy. Enhancing medication adherence and improving health outcomes for those living with COPD are among the key challenges for the global health community. This systematic review aims to identify the rate of nonadherence among people who are prescribed controller medication for the management of their COPD, and identifies the barriers and facilitators that influence their medication use behavior.
METHODS
A systematic search of medical databases (ie, MEDLINE, CINHAL, and EMBASE) was conducted using key words to identify literature in the English language, published between January 2003 and December 2019. Included studies were assessed for quality using the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist.
RESULTS
A total of 1,474 studies were identified from the initial database search, of which 38 met the inclusion criteria. Of these 38 studies, 37 reported on rates of nonadherence (ranging from 22% to 93%), 30 reported on barriers to adherence, 24 reported on enablers to adherence, and 16 reported on both. The majority (33) of the studies were conducted in high-income nations. The quality of articles ranged from 47% to 90%. Medication-taking behavior was reported to be influenced by several factors such as subjects' beliefs about medication, their experiences of and satisfaction with medication effectiveness, their concerns regarding medication side effects, their personal circumstances, habits and health status, and their relationships with health care providers.
CONCLUSIONS
Adherence to COPD medication was generally low, with the majority of studies identifying the presence of depression and subjects' concern about the harmful effects of the medicine as barriers to adherence. Variability exists on the reported rates of nonadherence, possibly due to different measures utilized to assess adherence. Future research in low-income nations is needed.
背景
尽管药物是 COPD 有效管理的一个组成部分,但当代研究报告称,超过一半的 COPD 患者接受药物治疗后并未坚持治疗。提高药物依从性并改善 COPD 患者的健康结果是全球卫生界面临的主要挑战之一。本系统评价旨在确定接受 COPD 管理处方控制器药物的患者的不依从率,并确定影响其药物使用行为的障碍和促进因素。
方法
使用关键词对 MEDLINE、CINHAL 和 EMBASE 等医学数据库进行系统搜索,以确定 2003 年 1 月至 2019 年 12 月期间发表的英文文献。使用观察性研究的强化报告标准(STROBE)检查表评估纳入研究的质量。
结果
从最初的数据库搜索中确定了 1474 项研究,其中 38 项符合纳入标准。这 38 项研究中有 37 项报告了不依从率(从 22%到 93%),30 项报告了依从性障碍,24 项报告了依从性促进因素,16 项报告了两者。大多数(33 项)研究在高收入国家进行。文章质量从 47%到 90%不等。药物使用行为受到多种因素的影响,例如患者对药物的看法、他们对药物有效性的体验和满意度、他们对药物副作用的担忧、他们的个人情况、习惯和健康状况,以及他们与医疗保健提供者的关系。
结论
对 COPD 药物的依从性总体较低,大多数研究都认为存在抑郁和患者对药物有害影响的担忧是依从性的障碍。不依从率的报告存在差异,可能是由于评估依从性的方法不同。需要在低收入国家开展进一步的研究。